Gilead Study Director
Gilead Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gilead Study Director as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:22 UTC. Showing 200 of 382. Open this list on ClinicalTrials.gov
- Ph2NCT07912996 · Study to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital HerpesGilead Sciences · not yet recruiting · HSV-2 Infection · study director
- Ph4NCT07908446 · Study of BIC/LEN FDC Versus Stable Baseline Regimens in Virologically Suppressed People With HIVGilead Sciences · not yet recruiting · HIV-1 Infection · study director
- Ph2NCT07841977 · Study of Seladelpar and Cilofexor in Participants With Primary Biliary CholangitisGilead Sciences · recruiting · Primary Biliary Cholangitis · study director
- Ph2NCT07841990 · Substudy-01: A Study of Long-Acting HIV-1 Treatments Taken by Mouth in People With HIV-1 With Undetectable Virus LevelsGilead Sciences · recruiting · HIV-1 Infection · study director
- Ph1NCT07719491 · Study of GS-0415 and How It Works in People With HIVGilead Sciences · recruiting · HIV -1 Infection · study director
- Ph2/Ph3NCT07708727 · Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentGilead Sciences · recruiting · HIV-1-infection · study director
- Ph1NCT07703878 · A Study to Evaluate the Safety and Antitumor Activity of GS-1206 in Adults With Solid TumorsGilead Sciences · recruiting · Solid Tumor · study director
- Ph3NCT07682961 · Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral TherapyGilead Sciences · recruiting · HIV Infections · study director
- Ph3NCT07683000 · Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment RegimensGilead Sciences · recruiting · HIV-1-infection · study director
- Ph2NCT07645287 · A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1Gilead Sciences · recruiting · HIV-1-infection · study director
- Ph1NCT07601243 · Study of GS-2426 in Participants With Advanced Solid TumorsGilead Sciences · recruiting · Advanced Solid Tumors · study director
- Ph2NCT07546812 · Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal AdenocarcinomasGilead Sciences · active not recruiting · HER2-negative, Gastroesophageal Junction, Esophageal Adenocarcinoma · study director
- Ph2NCT07527858 · Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal CancerGilead Sciences · recruiting · Advanced Microsatellite Stable Colorectal Cancer · study director
- N/ANCT07473778 · Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV PreventionGilead Sciences · recruiting · HIV Infections · study director
- Ph1NCT07128303 · Study of GS-5319 Given Alone or in Combination in Adults With Solid TumorsGilead Sciences · recruiting · Advanced Solid Tumor · study director
- Ph1NCT07115368 · Study of GS-1219 in Participants With HIV-1Gilead Sciences · terminated · HIV-1-infection · study director
- Ph1/Ph2NCT07096193 · Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta VirusGilead Sciences · recruiting · Chronic Hepatitis Delta · study director
- Ph1NCT07055451 · Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIVGilead Sciences · active not recruiting · HIV-1-infection · study director
- Ph3NCT07047716 · Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)Gilead Sciences · active not recruiting · HIV Pre-exposure Prophylaxis · study director
- Ph1NCT07001319 · Study of GS-3242 in Participants With HIV-1; Substudy-05Gilead Sciences · completed · HIV-1-infection · study director
- Ph1/Ph2NCT06926920 · A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast CancerGilead Sciences · recruiting · Triple Negative Breast Cancer · study director
- Ph1NCT06902519 · Study of GS-0151 in Participants With Rheumatoid ArthritisGilead Sciences · active not recruiting · Rheumatoid Arthritis · study director
- Ph3NCT06801834 · Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung CancerGilead Sciences · recruiting · Extensive Stage Small Cell Lung Cancer (ES-SCLC) · study director
- Ph2NCT06784973 · Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) InfectionGilead Sciences · terminated · RSV Infection · study director
- N/ANCT06780579 · Expanded Access for BulevirtideGilead Sciences · approved for marketing · Chronic Hepatitis Delta Virus Infection · study director
- Ph2NCT06749054 · Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and ChildrenGilead Sciences · recruiting · HIV-1-infection · study director
- Ph2NCT06727565 · Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01Gilead Sciences · active not recruiting · Head and Neck Squamous Cell Carcinoma · study director
- N/ANCT06683482 · A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in SpainGilead Sciences · completed · Breast Cancer · study director
- Ph2NCT06682234 · Study of Obeldesivir as Postexposure Prophylaxis for Filovirus Diseases Virus DiseaseGilead Sciences · withdrawn · Filovirus Disease, Postexposure Prophylaxis for Filovirus Disease · study director
- Ph3NCT06630286 · Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1Gilead Sciences · active not recruiting · HIV-1-infection · study director
- Ph3NCT06630299 · Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1Gilead Sciences · active not recruiting · HIV-1-Infection · study director
- Ph2/Ph3NCT06613685 · Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been TreatedGilead Sciences · terminated · HIV-1-infection · study director
- Ph2NCT06585150 · Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) InfectionGilead Sciences · terminated · RSV Infection · study director
- Ph1NCT06562907 · Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)Gilead Sciences · recruiting · Weight Management · study director
- Ph2/Ph3NCT06544733 · Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically SuppressedGilead Sciences · active not recruiting · HIV-1-Infection · study director
- Ph1NCT06532565 · Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid TumorsGilead Sciences · recruiting · Advanced Solid Tumors · study director
- Ph2/Ph3NCT06532656 · Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1Gilead Sciences · active not recruiting · HIV-1-infection · study director
- Ph2NCT06513312 · Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)Gilead Sciences · active not recruiting · Pre-Exposure Prophylaxis of HIV Infection · study director
- Ph3NCT06486441 · Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)Gilead Sciences · active not recruiting · Endometrial Cancer · study director
- Ph4NCT06337032 · A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV TreatmentsGilead Sciences · recruiting · HIV-1-infection · study director
- Ph3NCT06333808 · Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyGilead Sciences · active not recruiting · HIV-1-infection · study director
- Ph1/Ph2NCT06303505 · FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCGilead Sciences · recruiting · Ovarian Cancer, Non-small Cell Lung Cancer · study director
- Ph2NCT06290934 · Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative ColitisGilead Sciences · active not recruiting · Ulcerative Colitis · study director
- Ph1NCT06167317 · Study of GS-0201 Alone and in Combination in Participants With Advanced Solid TumorsGilead Sciences · recruiting · Advanced Solid Tumors · study director
- Ph4NCT06104306 · Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)Gilead Sciences · completed · HIV-1-infection · study director
- Ph2NCT06101329 · Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)Gilead Sciences · active not recruiting · Pre-Exposure Prophylaxis of HIV Infection · study director
- Ph2NCT06101342 · Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)Gilead Sciences · active not recruiting · Pre-Exposure Prophylaxis of HIV Infection · study director
- Ph1NCT06082960 · Study of GS-9911 With or Without Antibody Treatment for Adults With Solid TumorsGilead Sciences · active not recruiting · Solid Tumors · study director
- Ph3NCT06060665 · Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)Gilead Sciences · completed · Primary Biliary Cholangitis · study director
- Ph3NCT06051617 · Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated CirrhosisGilead Sciences · recruiting · Primary Biliary Cholangitis · study director
- Ph1NCT06031415 · Study of GS-0272 in Participants With Rheumatoid ArthritisGilead Sciences · terminated · Rheumatoid Arthritis · study director
- Ph2NCT06029972 · Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative ColitisGilead Sciences · active not recruiting · Ulcerative Colitis · study director
- Ph2/Ph3NCT05996744 · Study of Obeldesivir in Children and Adolescents With COVID-19Gilead Sciences · terminated · COVID-19 · study director
- Ph3NCT05840211 · Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine TherapyGilead Sciences · active not recruiting · Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer · study director
- Ph1NCT05840224 · Study of GS-4528 in Adults With Solid TumorsGilead Sciences · active not recruiting · Solid Tumor · study director
- Ph1NCT05770895 · Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis BGilead Sciences · completed · Chronic Hepatitis B · study director
- Ph1NCT05765344 · Study of Bulevirtide in Participants Who Have Normal or Impaired Liver FunctionGilead Sciences · completed · Hepatic Impairment, Healthy · study director
- Ph1NCT05760300 · A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal FunctionGilead Sciences · completed · Chronic Hepatitis D Infection · study director
- Ph2NCT05729568 · A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 InfectionGilead Sciences · active not recruiting · HIV-1 Infection · study director
- Ph3NCT05715528 · Study of Obeldesivir in Nonhospitalized Participants With COVID-19Gilead Sciences · completed · COVID-19 · study director
- N/ANCT05718700 · Study of Bulevirtide in Participants With Chronic Hepatitis D InfectionGilead Sciences · terminated · Chronic Hepatitis D Infection · study director
- Ph2NCT05676931 · Study With Various Immunotherapy Treatments in Participants With Lung CancerGilead Sciences · active not recruiting · Advanced Non-Small Cell Lung Cancer · study director
- Ph2NCT05633667 · Study of Novel Treatment Combinations in Patients With Lung CancerGilead Sciences · active not recruiting · Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer · study director
- Ph3NCT05633654 · Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Gilead Sciences · recruiting · Triple Negative Breast Cancer · study director
- Ph2NCT05629208 · Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)Gilead Sciences · terminated · Cutaneous Lupus Erythematosus (CLE) · study director
- N/ANCT05627466 · US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid LeukemiaGilead Sciences · no longer available · Relapsed/Refractory Acute Myeloid Leukemia · study director
- Ph3NCT05603143 · Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe IllnessGilead Sciences · terminated · COVID-19 · study director
- Ph1NCT05585307 · Study of Novel Antiretrovirals in Participants With HIV-1Gilead Sciences · completed · HIV-1-infection · study director
- Ph3NCT05502237 · Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung CancerGilead Sciences · active not recruiting · Non-small Cell Lung Cancer · study director
- Ph1NCT05458102 · Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus LevelsGilead Sciences · terminated · Human Immunodeficiency Virus Type 1 (HIV-1) Infection · study director
- Ph3NCT05382299 · Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerGilead Sciences · active not recruiting · Triple Negative Breast Cancer, PD-L1 Negative · study director
- Ph3NCT05382286 · Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerGilead Sciences · active not recruiting · Triple Negative Breast Cancer, PD-L1 Positive · study director
- Ph2NCT05330429 · Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)Gilead Sciences · terminated · Metastatic Colorectal Cancer · study director
- Ph2NCT05281510 · Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected WomenGilead Sciences · completed · HIV-1-infection · study director
- Ph2NCT05186974 · Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)Gilead Sciences · active not recruiting · Non-small Cell Lung Cancer · study director
- Ph2NCT05165771 · Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) TreatmentGilead Sciences · withdrawn · Rheumatoid Arthritis · study director
- Ph2NCT05119907 · Study of Sacituzumab Govitecan in Patients With Solid TumorGilead Sciences · active not recruiting · Solid Tumor · study director
- Ph1/Ph2NCT05101096 · Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid TumorsGilead Sciences · active not recruiting · Advanced Solid Tumor, Metastatic Triple-Negative Breast Cancer, HR+/HER2- Metastatic Breast Cancer · study director
- Ph3NCT05089734 · Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Gilead Sciences · active not recruiting · Non-Small Cell Lung Cancer · study director
- Ph3NCT05079230 · Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid LeukemiaGilead Sciences · terminated · Acute Myeloid Leukemia · study director
- Ph2NCT05052996 · Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIVGilead Sciences · active not recruiting · HIV-1 Infection · study director
- Ph1NCT05006794 · Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid MalignanciesGilead Sciences · terminated · Solid Malignancies · study director
- Ph1NCT05007782 · Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid TumorsGilead Sciences · active not recruiting · Advanced Solid Tumor · study director
- Ph3NCT04994509 · Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV InfectionGilead Sciences · active not recruiting · Pre-Exposure Prophylaxis of HIV Infection · study director
- Ph2NCT04971785 · Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)Gilead Sciences · completed · Nonalcoholic Steatohepatitis · study director
- Ph2NCT04958785 · Study of Magrolimab Combination Therapy in Patients With Non-Surgically Removable Locally Advanced or Metastatic Triple-Negative Breast CancerGilead Sciences · terminated · Triple-Negative Breast Cancer · study director
- Ph1NCT04950764 · An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)Gilead Sciences · completed · Primary Biliary Cholangitis, Compensated Cirrhosis, Hepatic Impairment · study director
- Ph3NCT04925752 · Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV InfectionGilead Sciences · active not recruiting · Pre-Exposure Prophylaxis of HIV Infection · study director
- Ph2NCT04892446 · Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple MyelomaGilead Sciences · terminated · Multiple Myeloma · study director
- Ph2NCT04891770 · Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)Gilead Sciences · completed · Chronic Hepatitis B · study director
- Ph2NCT04854499 · Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell CarcinomaGilead Sciences · terminated · Head and Neck Squamous Cell Carcinoma · study director
- Ph2NCT04827576 · Study of Magrolimab in Patients With Solid TumorsGilead Sciences · terminated · Solid Tumor · study director
- Ph2NCT04827589 · Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous UrticariaGilead Sciences · withdrawn · Chronic Spontaneous Urticaria · study director
- Ph1NCT04811040 · Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 InfectionGilead Sciences · completed · HIV-1 Infection · study director
- Ph1NCT04809623 · Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)Gilead Sciences · terminated · Cutaneous Lupus Erythematosus · study director
- Ph3NCT04778397 · Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been TreatedGilead Sciences · terminated · Acute Myeloid Leukemia · study director
- Ph2NCT04778410 · Study of Magrolimab Combinations in Participants With Myeloid MalignanciesGilead Sciences · terminated · Myeloid Malignancies · study director
- Ph1NCT04747470 · Study to Assess the Effects of GS-3583 in Participants With Advanced Solid TumorsGilead Sciences · terminated · Advanced Solid Tumors · study director
- Ph3NCT04745351 · Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)Gilead Sciences · terminated · COVID-19 · study director
- Ph3NCT04639986 · Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)Gilead Sciences · active not recruiting · Metastatic Breast Cancer · study director
- Ph1NCT04617522 · Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver ImpairmentGilead Sciences · recruiting · Advanced or Metastatic Solid Tumor, Liver Failure · study director
- Ph1NCT04608344 · Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy ParticipantsGilead Sciences · completed · Rheumatoid Arthritis · study director
- Ph1/Ph2NCT04539262 · Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by InhalationGilead Sciences · completed · COVID-19 · study director
- Ph3NCT04527991 · Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadGilead Sciences · completed · Locally Advanced or Metastatic Unresectable Urothelial Cancer · study director
- Ph3NCT04501952 · Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient SettingGilead Sciences · terminated · COVID-19 · study director
- Ph1NCT04502706 · Study of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin LymphomaGilead Sciences · terminated · Non-hodgkin Lymphoma · study director
- Ph3NCT04483700 · Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug TherapyGilead Sciences · withdrawn · Ankylosing Spondylitis · study director
- Ph3NCT04483687 · Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug TherapyGilead Sciences · withdrawn · Ankylosing Spondylitis · study director
- Ph2NCT04454437 · Study of Sacituzumab Govitecan in Chinese Patients With Metastatic Triple-negative Breast Cancer Who Received at Least Two Prior TreatmentsGilead Sciences · active not recruiting · Metastatic Triple-negative Breast Cancer · study director
- Ph2/Ph3NCT04431453 · Study of Remdesivir in Participants Below 18 Years Old With COVID-19Gilead Sciences · completed · COVID-19 · study director
- N/ANCT04323761 · Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)Gilead Sciences · approved for marketing · SARS-CoV2 Infection · study director
- Ph4NCT04319198 · Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziyGilead Sciences · completed · Metastatic Solid Tumors · study director
- Ph3NCT04313881 · Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)Gilead Sciences · terminated · Myelodysplastic Syndromes · study director
- Ph3NCT04292899 · Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)Gilead Sciences · completed · COVID-19 · study director
- Ph3NCT04292730 · Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care TreatmentGilead Sciences · completed · COVID-19 · study director
- Ph3NCT04211909 · Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) InfectionGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph2/Ph3NCT04150068 · Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug ResistanceGilead Sciences · active not recruiting · HIV-1-infection · study director
- Ph2NCT04143594 · Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIVGilead Sciences · completed · HIV-1-infection · study director
- Ph2NCT04130919 · Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative ColitisGilead Sciences · terminated · Ulcerative Colitis · study director
- Ph3NCT04115839 · Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD TherapyGilead Sciences · terminated · Psoriatic Arthritis · study director
- Ph3NCT04115748 · Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD TherapyGilead Sciences · terminated · Psoriatic Arthritis · study director
- Ph3NCT04112303 · Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated CirrhosisGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph1NCT04060147 · Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated CirrhosisGilead Sciences · terminated · Primary Sclerosing Cholangitis, Compensated Cirrhosis · study director
- Ph1NCT04049617 · Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid TumorsGilead Sciences · terminated · Advanced Solid Tumors · study director
- Ph2NCT04026165 · Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney DiseaseGilead Sciences · completed · Diabetic Kidney Disease · study director
- Ph2NCT04024813 · A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSCGilead Sciences · terminated · Primary Sclerosing Cholangitis · study director
- N/ANCT04009057 · Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir Alafenamide (B/F/TAF)Gilead Sciences · completed · HIV-1-infection · study director
- Ph2NCT03987074 · Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)Gilead Sciences · completed · Nonalcoholic Steatohepatitis · study director
- Ph2NCT03964727 · Study of Sacituzumab Govitecan in Participants With Metastatic Solid TumorsGilead Sciences · active not recruiting · Metastatic Solid Tumor · study director
- Ph1NCT03960645 · Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third TrimestersGilead Sciences · completed · HIV-1-infection · study director
- Ph1NCT03954704 · Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid TumorsGilead Sciences · terminated · Advanced Solid Tumors · study director
- Ph3NCT03901339 · Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerGilead Sciences · completed · Metastatic Breast Cancer · study director
- Ph3NCT03890120 · Study of Cilofexor in Adults With Primary Sclerosing CholangitisGilead Sciences · terminated · Primary Sclerosing Cholangitis · study director
- Ph2NCT03820258 · Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) InfectionGilead Sciences · terminated · Hepatitis C Virus Infection · study director
- Ph1NCT03739866 · Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected AdultsGilead Sciences · completed · HIV-1 Infection · study director
- N/ANCT03701438 · Immune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With IdelalisibGilead Sciences · terminated · B-cell Malignancies · study director
- Ph3NCT03631732 · Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American ParticipantsGilead Sciences · completed · HIV-1 Infection · study director
- Ph2NCT03615066 · Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on TreatmentGilead Sciences · completed · Chronic Hepatitis B · study director
- N/ANCT03582098 · Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and IrelandGilead Sciences · completed · Chronic Lymphocytic Leukaemia · study director
- N/ANCT03580668 · Effectiveness, Safety, Adherence, and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir/ Emtricitabine/Tenofovir AlafenamideGilead Sciences · completed · HIV-1-infection · study director
- N/ANCT03568929 · Safety Profile of Idelalisib in Patients With Refractory Follicular LymphomaGilead Sciences · completed · Follicular Non-Hodgkin's Lymphoma Refractory · study director
- Ph1NCT03558139 · Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum ChemotherapyGilead Sciences · completed · Ovarian Cancer · study director
- Ph3NCT03547908 · Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected AdultsGilead Sciences · completed · HIV-1/HBV Co-Infection · study director
- Ph2NCT03547973 · Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadGilead Sciences · active not recruiting · Metastatic Urothelial Cancer · study director
- Ph2NCT03491553 · Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis BGilead Sciences · completed · Chronic Hepatitis B · study director
- Ph2NCT03472326 · Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant VirusGilead Sciences · terminated · HIV-1-infection · study director
- Ph2NCT03449446 · Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)Gilead Sciences · completed · Nonalcoholic Steatohepatitis · study director
- Ph2NCT03434353 · Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)Gilead Sciences · terminated · Chronic Hepatitis B · study director
- Ph1NCT03417778 · Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic FunctionGilead Sciences · completed · Rheumatoid Arthritis · study director
- Ph3NCT03405935 · Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 YearsGilead Sciences · completed · HIV-1 Infection · study director
- Ph1NCT03349346 · Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and AdolescentsGilead Sciences · withdrawn · Diffuse Large B-Cell Lymphoma, Mediastinal B-cell Lymphoma · study director
- Ph3NCT03301506 · Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)Gilead Sciences · active not recruiting · Primary Biliary Cirrhosis · study director
- Ph1NCT03248479 · Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological MalignanciesGilead Sciences · terminated · Hematological Malignancies · study director
- Ph3NCT03219164 · Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa BacteriaGilead Sciences · terminated · Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization, Cystic Fibrosis · study director
- Ph2NCT03207815 · Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious UveitisGilead Sciences · terminated · Noninfectious Uveitis · study director
- Ph2NCT03180619 · Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)Gilead Sciences · completed · Chronic Hepatitis B · study director
- Ph1NCT03135028 · Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese AdultsGilead Sciences · terminated · Hematologic Malignancy, Acute Myeloid Leukemia · study director
- Ph2NCT03134222 · Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)Gilead Sciences · completed · Cutaneous Lupus Erythematosus · study director
- Ph3NCT03118843 · Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment StudyGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph3NCT03110380 · Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Adults Who Are Virologically SuppressedGilead Sciences · completed · HIV-1-infection · study director
- Ph2NCT03100942 · Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's SyndromeGilead Sciences · completed · Sjogren's Syndrome · study director
- Ph2NCT03077412 · Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's DiseaseGilead Sciences · completed · Fistulizing Crohn's Disease · study director
- Ph3NCT03074331 · Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) InfectionGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph1NCT03060447 · Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected ControllersGilead Sciences · completed · HIV-1 Infection · study director
- Ph3NCT03053050 · Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) FibrosisGilead Sciences · terminated · Nonalcoholic Steatohepatitis · study director
- Ph3NCT03053063 · Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)Gilead Sciences · terminated · Nonalcoholic Steatohepatitis · study director
- Ph2NCT03046056 · Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)Gilead Sciences · completed · Small Bowel Crohn's Disease · study director
- Ph2NCT03036852 · Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal DiseaseGilead Sciences · completed · Chronic Hepatitis C · study director
- Ph2NCT03036839 · Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal DiseaseGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph2NCT03022981 · Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV InfectionGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph3NCT02996682 · Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated CirrhosisGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph2NCT02994056 · Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C CirrhosisGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph2NCT02983617 · Safety and Efficacy of the Combination of Tirabrutinib and Entospletinib With and Without Obinutuzumab in Adults With Chronic Lymphocytic Leukemia (CLL)Gilead Sciences · completed · Chronic Lymphocytic Leukemia · study director
- Ph1/Ph2NCT02983604 · GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast CancerGilead Sciences · terminated · Advanced Estrogen Receptor Positive HER2- Breast Cancer · study director
- Ph3NCT02979613 · Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically SuppressedGilead Sciences · completed · Chronic Hepatitis B · study director
- Ph2NCT02968563 · Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Gilead Sciences · completed · Chronic Lymphocytic Leukemia · study director
- Ph1NCT02959138 · Pharmacokinetics of Lanraplenib in Adults With Impaired Renal FunctionGilead Sciences · completed · Inflammatory Disease · study director
- Ph1/Ph2NCT02953782 · Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal CancerGilead Sciences · completed · Solid Tumor, Colorectal Cancer · study director
- Ph1/Ph2NCT02953509 · Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's LymphomaGilead Sciences · terminated · Non Hodgkin Lymphoma · study director
- N/ANCT02951364 · Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in KoreaGilead Sciences · completed · Hepatitis C Virus · study director
- Ph2NCT02943447 · Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without CirrhosisGilead Sciences · terminated · Primary Biliary Cholangitis · study director
- Ph2NCT02943460 · Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without CirrhosisGilead Sciences · completed · Primary Sclerosing Cholangitis · study director
- Ph2NCT02932150 · Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus InfectionGilead Sciences · active not recruiting · Chronic Hepatitis B · study director
- Ph3NCT02914522 · Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative ColitisGilead Sciences · completed · Ulcerative Colitis · study director
- N/ANCT02907996 · Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in KoreaGilead Sciences · completed · Hepatitis C Virus · study director
- Ph3NCT02889796 · Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateGilead Sciences · completed · Rheumatoid Arthritis · study director
- Ph1NCT02891408 · Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic FunctionGilead Sciences · completed · Nonalcoholic Steatohepatitis (NASH) · study director
- Ph3NCT02886728 · Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX TherapyGilead Sciences · completed · Rheumatoid Arthritis · study director
- Ph2NCT02885181 · Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With MethotrexateGilead Sciences · completed · Rheumatoid Arthritis · study director
- Ph2/Ph3NCT02881320 · Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1Gilead Sciences · active not recruiting · HIV-1 Infection · study director
- Ph3NCT02873936 · Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) TreatmentGilead Sciences · completed · Rheumatoid Arthritis · study director
- Ph2NCT02868242 · Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer ChemotherapyGilead Sciences · completed · Hepatitis C Virus Infection · study director
- Ph2NCT02864381 · Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction AdenocarcinomaGilead Sciences · completed · Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma · study director
- Ph1NCT02862535 · Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction AdenocarcinomaGilead Sciences · terminated · Gastric Adenocarcinoma · study director
- Ph2NCT02862574 · Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid ArthritisGilead Sciences · terminated · Rheumatoid Arthritis · study director
- Ph2NCT02862548 · Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver TransplantGilead Sciences · completed · Chronic Hepatitis B · study director
- Ph1NCT02858401 · Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed AdultsGilead Sciences · completed · HIV-1 Infection · study director
- Ph2NCT02856555 · Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic SteatohepatitisGilead Sciences · completed · Nonalcoholic Steatohepatitis (NASH) · study director
- Ph2NCT02854631 · Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)Gilead Sciences · completed · Alcoholic Hepatitis (AH) · study director
- Ph2NCT02854605 · Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)Gilead Sciences · completed · Nonalcoholic Steatohepatitis (NASH) · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.